Infant Bacterial Therapeutics AB (publ) Stock Forecast
Red day on Thursday for Infant Bacterial Therapeutics AB (publ)
(Updated on May 16, 2024)
The Infant Bacterial Therapeutics AB (publ) stock price fell by -1.84% on the last day (Thursday, 16th May 2024) from kr97.80 to kr96.00. During the last trading day the stock fluctuated 4.67% from a day low at kr94.20 to a day high of kr98.60. The price has risen in 6 of the last 10 days and is up by 8.84% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -14 thousand shares and in total, 4 thousand shares were bought and sold for approximately kr423.84 thousand.
The stock lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at kr99.30 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 9.62% during the next 3 months and, with a 90% probability hold a price between kr90.32 and kr108.85 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
IBT-B.ST Signals & Forecast
The Infant Bacterial Therapeutics AB (publ) stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at kr93.74 and kr86.59. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, May 14, 2024, and so far it has fallen -3.03%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for Infant Bacterial Therapeutics AB (publ) stock
On the downside, the stock finds support just below today's level from accumulated volume at kr85.80 and kr80.00. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Infant Bacterial Therapeutics AB (publ) finds support just below today's level at kr85.80. If this is broken, then the next support from accumulated volume will be at kr80.00 and kr76.40.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved kr4.40 between high and low, or 4.67%. For the last week the stock has had daily average volatility of 6.25%.
Our recommended stop-loss: kr91.46 (-4.73%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 2 days ago.)
Trading Expectations (IBT-B.ST) For The Upcoming Trading Day Of Friday 17th
For the upcoming trading day on Friday, 17th we expect Infant Bacterial Therapeutics AB (publ) to open at kr96.27, and during the day (based on 14 day Average True Range), to move between kr91.51 and kr100.49, which gives a possible trading interval of +/-kr4.49 (+/-4.68%) up or down from last closing price. If Infant Bacterial Therapeutics AB (publ) takes out the full calculated possible swing range there will be an estimated 9.36% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at kr97.80 (1.88%) than the support at kr85.80 (10.63%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Infant Bacterial Therapeutics AB (publ) stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Infant Bacterial Therapeutics AB (publ) stock to perform well in the short-term.
Current score: 2.180 Buy Candidate Unchanged
Predicted Opening Price for Infant Bacterial Therapeutics AB (publ) of Friday, May 17, 2024
Fair opening price May 17, 2024 | Current price |
---|---|
kr96.27 ( 0.278%) | kr96.00 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for IBT-B.ST
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 100.67 | 4.86 % | |
R2 | 98.99 | 3.11 % | ||
R1 | 97.95 | 2.03 % | ||
Current price: | 96.00 | |||
Support | S1 | 94.59 | -1.47 % | |
S2 | 93.55 | -2.55 % | ||
S3 | 91.87 | -4.31 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0 | . | |
R2 | 99.00 | 3.13 % | ||
R1 | 97.80 | 1.88 % | ||
Current price | 96.00 | |||
Support | S1 | 85.80 | -10.63% | |
S2 | 80.00 | -16.67% | ||
S3 | 76.40 | -20.42% |
FAQ
Click here for our free guide on how to buy Infant Bacterial Therapeutics AB (publ) Stock.